Ketamine Therapy by Condition

This article explains why therapy and antidepressants often fail to relieve prolonged grief, what the clinical evidence shows about treatments designed specifically for grief, and what Mindbloom's published outcomes research found in 503 bereaved adults treated with ketamine-assisted therapy.

If you have been on anxiety medication, completed a course of therapy, or both, and you are still not getting enough relief, you are in a situation many people face. Published response rates for first-line anxiety medication cluster around 60 to 75%, meaning roughly one in three patients does not respond fully.¹ This article covers the next-step options to discuss with your provider: checking whether your current treatment is working as well as it can, lifestyle strategies that help, therapy beyond standard talk therapy, additional medications worth considering, and interventional treatments like ketamine therapy, TMS, and ECT.

If PTSD has been part of your life for a while, you've probably tried, or at least considered, the standard treatments. SSRIs. Trauma-focused therapy. Both are effective for many people, but the wait to feel better is typically measured in months. Ketamine works on a different timeline, and this article explains why, what the research shows about how quickly relief begins, and what to expect across a full course of treatment.

When standard PTSD treatments don't fully resolve symptoms, understanding your options is the first step toward finding what works. This article covers why symptoms sometimes persist after first-line care, how to reassess your current treatment plan, and which evidence-based advanced treatments are worth discussing with your provider.

Chronic insomnia that persists despite standard sleep advice, medication, and behavioral changes usually has an identifiable root cause that has not yet been addressed. This article covers the full treatment landscape, from cognitive behavioral therapy and sleep aids to integrative approaches and mood-targeted treatments, to help you find the right next step.

This article reviews the evidence-based alternatives to antidepressants for depression, including psychotherapy, lifestyle modifications, device-based treatments, and ketamine therapy, so you can make an informed decision with your care team.

This article explains the most effective evidence-based treatments for treatment-resistant depression, including medication strategies, psychotherapy, brain stimulation, and ketamine therapy, and covers how to choose the right approach based on symptom severity, treatment history, and access to care.

Anxiety disorders respond to a range of treatments — from talk therapy and medication to lifestyle changes and ketamine-assisted therapy — and the right approach depends on your diagnosis, symptom severity, and personal goals. This article compares the evidence behind each option to help you and your provider make an informed decision.

Social anxiety disorder is a recognized psychiatric condition that responds well to treatment, yet many people go years without accessing effective care. This article covers the full range of evidence-based options, including cognitive behavioral therapy, SSRIs, and ketamine therapy, along with how they compare and what to expect from a structured treatment program.

Ketamine is an FDA-approved anesthetic with decades of medical use that licensed providers now prescribe off-label for refractory chronic migraine, mood disorders, and other conditions. This article covers how ketamine works on migraine pain signals, when specialists consider it, how it is administered, and what the safety profile looks like.

Ketamine helps depression through a fundamentally different biological pathway than traditional antidepressants, targeting glutamate signaling and synaptic neuroplasticity rather than serotonin. This article explains how those mechanisms work, what the research shows about outcomes and safety, and what a structured treatment program involves.

Gambling disorder is a recognized behavioral addiction with effective, evidence-based treatments — and this article covers the full care landscape, from CBT and medication to relapse prevention strategies and how treating co-occurring depression or anxiety supports lasting recovery.

Burnout causes measurable neurobiological changes — including synaptic atrophy and stress-hormone dysregulation — that resist simple lifestyle fixes. This article explains how ketamine targets those specific mechanisms, what the evidence shows for burnout-related symptoms like depression and anxiety, and what a structured treatment program looks like in practice.

Ketamine therapy is well established for depression, anxiety, and PTSD — but researchers are now examining whether its neuroplastic mechanisms may also support nicotine cessation. This article explains what the current evidence shows, how ketamine's effects on brain flexibility and mood may apply to addiction patterns, and what a protocol-driven quit plan looks like in practice.

Ketamine therapy may reduce panic attack frequency and intensity by targeting the brain's fear circuitry and promoting neuroplasticity. This article covers the clinical evidence, how ketamine's mechanism differs from traditional anxiety medications, what to expect during treatment, and how to evaluate a clinician-supervised program.

Postpartum depression affects an estimated 1 in 7 people after childbirth, and this article reviews what the current clinical evidence shows about ketamine therapy as a treatment option, how its mechanism of action addresses core postpartum symptoms, and how it compares to established treatments like SSRIs, brexanolone, and zuranolone.

This article explains how ketamine therapy may reduce OCD symptoms, why its glutamate-based mechanism differs from standard SSRI treatment, what the clinical research shows, and what to expect from a clinician-supervised treatment program.

Ketamine is a clinically established medication used off-label for chronic pain when conventional treatments provide incomplete relief. This article explains how ketamine modulates pain signaling in the nervous system, which conditions it is most studied for, how different administration routes compare, and what a clinician-supervised treatment protocol involves.